These findings are in agreement with published studies suggesting that SPP1 loss ameliorates aggressiveness of pancreatic cancer cells (Kolb et al., 2005; Adams et al., 2019) and colon cancer cells (Zhao et al., 2018; Ishigamori et al., 2017). Here, SPP1 is linked to pancreatic neoplasm.